Marjolein Appelman, Rimke Oostvogels, Annemiek Broijl, Laurens Franssen, Paul Geerts, Ellen van der Spek, Heleen de Lil, Cleo van Rooijen, Paula Ypma, Monique Minnema, Wilfried Roeloffzen, Catharina van Elsen, Elizabeth de Kort, Kaz Groen, Inger Nijhof, Ruth Wester
{"title":"真实世界双特异性抗体治疗多发性骨髓瘤:来自荷兰全国注册的见解","authors":"Marjolein Appelman, Rimke Oostvogels, Annemiek Broijl, Laurens Franssen, Paul Geerts, Ellen van der Spek, Heleen de Lil, Cleo van Rooijen, Paula Ypma, Monique Minnema, Wilfried Roeloffzen, Catharina van Elsen, Elizabeth de Kort, Kaz Groen, Inger Nijhof, Ruth Wester","doi":"10.1016/S2152-2650(25)03471-8","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Pages S45-S46"},"PeriodicalIF":2.7000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Real-World Bispecific Antibody Therapy for Multiple Myeloma: Insights from Dutch Nationwide Registry\",\"authors\":\"Marjolein Appelman, Rimke Oostvogels, Annemiek Broijl, Laurens Franssen, Paul Geerts, Ellen van der Spek, Heleen de Lil, Cleo van Rooijen, Paula Ypma, Monique Minnema, Wilfried Roeloffzen, Catharina van Elsen, Elizabeth de Kort, Kaz Groen, Inger Nijhof, Ruth Wester\",\"doi\":\"10.1016/S2152-2650(25)03471-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10348,\"journal\":{\"name\":\"Clinical Lymphoma, Myeloma & Leukemia\",\"volume\":\"25 \",\"pages\":\"Pages S45-S46\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Lymphoma, Myeloma & Leukemia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2152265025034718\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma, Myeloma & Leukemia","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2152265025034718","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
期刊介绍:
Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.